<i>OASIS/CREB3L1</i> is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration <i>in vitro</i>

<div><p><i>CREB3L1</i> has been recently proposed as a novel metastasis suppressor gene in breast cancer. Our current study highlights CREB3L1 expression, regulation, and function in bladder cancer. We demonstrate a significant downregulation of <i>CREB3L1</i> mRNA expression (n = 64) in primary bladder cancer tissues caused by tumor-specific <i>CREB3L1</i> promoter hypermethylation (n = 51). Based on pyrosequencing <i>CREB3L1</i> methylation was shown to be potentially associated with a more aggressive phenotype of bladder cancer. These findings were verified by an independent public data set containing data from 184 bladder tumors. In addition, immunohistochemical evaluation showed that CREB3L1 protein expression is decreased in bladder cancer tissues as well. Interestingly, protein loss is predominately observed in the nuclei of aggressive tumor cells. Based on <i>in vitro</i> models we clearly show that CREB3L1 re-expression mediates suppression of tumor cell migration and colony growth of high grade and invasive bladder cancer cells. The candidate tumor suppressor and TGF-β signaling inhibitor HTRA3 was furthermore identified as putative target gene of CREB3L1 in both invasive J82 bladder cells and primary bladder tumors. Hence, our data provide for the first time evidence that the transcription factor CREB3L1 may have an important role as a putative tumor suppressor in bladder cancer.</p></div